True quality system maturity requires a fundamental shift: moving from retrospective quality metrics to predictive compliance signals. Instead of just tracking volume, executives must analyze deviation recurrence, CAPA effectiveness, and hidden patterns across their eQMS. By leveraging specialized AI agents to monitor these signals under human oversight, organizations can detect process drift and emerging vulnerabilities long before they trigger regulatory scrutiny.
Most life sciences organizations are drowning in quality data but starving for actionable intelligence. Dashboards boasting 99% training completion or 95% on-time CAPA closures might create a false sense of security, often masking systemic risks like repeat deviations and underlying human error. If your leadership team is only counting closed records, you are simply documenting history rather than preventing future failures.
Are your current KPIs giving you an early warning, or just explaining what went wrong last quarter?
Discover the specific compliance signals your executive team should be measuring and learn how to turn your data into credible, forward-looking evidence of control.
Download the full article by EVERSANA experts Gregg Sherman and Thomas Barton.
Author
Gregg has over 25+ years of overseeing the development and management of quality processes and systems to achieve quality, compliance, and operational goals. He is a quality and compliance leader with a depth of…
With more than 20 years of experience in information management, computer system validation and GxP system support, Thomas leads the business process team supporting regulated systems for medical information services and pharmacovigilance and has…